SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:02+00:00 December 31st, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

SGOC [SGOCO] 6-K: SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian)

[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []

TPI [TIANYIN PHARMACEUTICAL] 10-Q:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:55+00:00 December 31st, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

SPU [SkyPeople Fruit Juice] 8-K: (Original Filing)

[Paritz & Company, P.A. 15 Warren Street, Suite 25 Hackensack, New Jersey 07601 (201)342-7753 Fax: (201) 342-7598 Certified Public Accountants December 31, 2014 100 F Street, N.E. Dear Sirs/Madams: We have read Item 4.01 of SkyPeople Fruit Juice, Inc.’s Form 8-K dated December 31, 2014 and we agree with the statements contained therein concerning our firm. Very truly yours, EX-16.1] []

SPU [SkyPeople Fruit Juice] 8-K: Paritz & Company, P.A. 15 Warren Street, Suite

[Paritz & Company, P.A. 15 Warren Street, Suite 25 Hackensack, New Jersey 07601 (201)342-7753 Fax: (201) 342-7598 Certified Public Accountants December 31, 2014 100 F Street, N.E. Dear Sirs/Madams: We have read Item 4.01 of SkyPeople Fruit Juice, Inc.’s Form 8-K dated December 31, 2014 and we agree with the statements contained therein concerning our firm. Very truly yours, EX-16.1] []

KNDI [Kandi Technologies] 8-K: (Original Filing)

[2014 Annual Shareholders Meeting Q&A 2014 年股东年会问答部分双语记录稿 The Bilingual Transcript for the Q&A Session for the 2014 Annual Shareholders Meeting 1. Q: Questions about production capacity on existing and two new facilities A: At present, Changxing and Shanghai’s designed annual facility capacity is 100k units, respectively. Jinhua’s designed annual facility capacity is 30k units. Rugao and Wanning facilities will each] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 30, 2014 KANDI TECHNOLOGIES GROUP, INC. Delaware 001-33997 90-0363723 (State of Incorporation) (IRS Employer Identification) Jinhua City Industrial Zone Post Code 321016 (86-579) 8223-9700 [ ] [ ] [ ] [ ] Item 5.07 Submission of Matters to a Vote of Security Holders. Proposal 1: Election of]

By | 2016-03-13T08:13:03+00:00 December 31st, 2014|Categories: Chinese Stocks, KNDI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar